NDC 57483-410

Xyralid Hemorrhoidal

Hemorrhoidal Suppositories

Xyralid Hemorrhoidal is a Rectal Suppository in the Human Otc Drug category. It is labeled and distributed by Innovus Pharmaceuticals, Inc.. The primary component is Cocoa Butter; Phenylephrine Hydrochloride.

Product ID57483-410_cd6eb255-a89d-40c5-90a0-13f907ab0ad5
NDC57483-410
Product TypeHuman Otc Drug
Proprietary NameXyralid Hemorrhoidal
Generic NameHemorrhoidal Suppositories
Dosage FormSuppository
Route of AdministrationRECTAL
Marketing Start Date2018-03-25
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart346
Labeler NameInnovus Pharmaceuticals, Inc.
Substance NameCOCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredient Strength89 g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 57483-410-13

4 BLISTER PACK in 1 CARTON (57483-410-13) > 24 g in 1 BLISTER PACK (57483-410-12)
Marketing Start Date2018-03-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 57483-410-12 [57483041012]

Xyralid Hemorrhoidal SUPPOSITORY
Marketing CategoryOTC monograph final
Application Numberpart346
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-03-25

NDC 57483-410-13 [57483041013]

Xyralid Hemorrhoidal SUPPOSITORY
Marketing CategoryOTC monograph final
Application Numberpart346
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-03-25

Drug Details

Active Ingredients

IngredientStrength
COCOA BUTTER88.5 g/100g

OpenFDA Data

SPL SET ID:8a885822-42e7-44e0-82d6-fa967123866e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1438497

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.